Meetgyl-ANO Cream is a topical formulation combining Lidocaine (4% w/w), Metronidazole (1% w/w), and Sucralfate (7% w/w), designed for the management of anorectal disorders characterized by pain, inflammation, and infection. Lidocaine, a local anesthetic, provides rapid symptomatic relief by blocking nerve conduction, thereby alleviating pain and discomfort associated with conditions such as hemorrhoids, anal fissures, and post-anal surgery. Metronidazole, an effective nitroimidazole antimicrobial agent, targets anaerobic bacteria and protozoa, reducing local infection and inflammation. Sucralfate acts as a cytoprotective agent, forming a protective barrier over ulcerated or inflamed mucosa, promoting tissue healing and reducing irritation. The synergistic combination of these agents in Meetgyl-ANO Cream facilitates comprehensive management by addressing pain, infection, and mucosal repair concurrently. This formulation is intended for topical application to the affected anorectal area, ensuring localized action with minimal systemic absorption. It is suitable for adult patients requiring symptomatic relief and infection control in anorectal conditions. Usage should follow medical advice, with attention to contraindications such as hypersensitivity to any component. Regular application as prescribed enhances therapeutic outcomes, improving patient comfort and accelerating recovery.